Cormorant Asset Management's book
39 companies · priced for members| Company | Industry | Valuation | $/share | First invested | Role |
|---|---|---|---|---|---|
| Freenome | Decision/Risk Analysis | ▮ | ▮ | ▮ | ▮ |
| Neurona Therapeutics | Drug Discovery | ▮ | ▮ | ▮ | ▮ |
| Parabilis Medicines | Drug Discovery | ▮ | ▮ | ▮ | ▮ |
+ 36 more companies · all 39, priced and dated or a free account shows the top 10 names — no card Membership and data by Private Market View | |||||
Cormorant Asset Management portfolio at a glance
39 portfolio companies are on record for Cormorant Asset Management, including Freenome, Neurona Therapeutics and Parabilis Medicines.
33 of the 39 carry a recorded valuation.
Free account
See more of the book
- ·The top 10 names in the book — of 39 recorded positions
- ·Watchlist + alerts for Cormorant Asset Management's activity